Relationship between serum bilirubin and ischaemic stroke outcomes
Study | Outcomes reported | Major findings | ||||||||
Outcome 1 | Unit | Follow-up point (days) | Outcome 2 | Unit | Follow-up point (days) | Outcome 3 | Unit | Follow-up point (days) | ||
Bhatia et al 65 | Death | Mortality | 30 | Bilirubin did not differ significantly in the survivors and expired stroke patients. | ||||||
Perlstein et al 35 | Adverse stroke outcomes | A ‘Physical Function’ questionnaire | 1 | Higher TBIL level is associated with improved stroke outcomes. | ||||||
Pineda et al 61 | Neurological impairment | NIHSS score | 1 | Death or disability | mRS | At discharge | Poor functional outcome | mRS score >3 | At discharge | Higher DBIL level is associated with greater stroke severity but not functional outcome among ischaemic stroke patients. |
Kurzepa et al 54 | Functional disability | BI score | 90 | Neurological impairment | NIHSS score | 1, 3, 5 and 10 | Serum bilirubin levels are poor prognostic factors for ischaemic stroke. | |||
Arsalan et al 53 | Neurological impairment | NIHSS score | 7.25 (at discharge) | Death or disability | mRS | 7.25 (at discharge) | Poor functional outcome | mRS score was from 4 to 6 | 7.25 (at discharge) | Higher serum bilirubin levels were associated with increased stroke severity, longer hospitalisation and poor prognosis. |
Luo et al 57 | Neurological impairment | NIHSS score | 1 | Relative severe stroke | NIHSS score ≥8 | 1 | Serum bilirubins were in significant correlation with severity of AIS. | |||
Luo et al 3 | Neurological impairment | NIHSS score | 1 | Relative severe stroke | NIHSS score ≥8 | 1 | The serum levels of DBIL and TBIL were increased after AIS, which linked to the severity of stroke. | |||
Markaki et al 60 | Death | Mortality | 28 months | Bilirubin is an independent predictor of mortality in ischaemic cerebrovascular disease patients (ischaemic stroke and transient ischaemic attack). | ||||||
Xu et al 58 | Neurological impairment | NIHSS score | 1 | Higher severity | NIHSS score ≥10 | 1 | Short-term clinical outcomes | NIHSS ≥10 at discharge or in-hospital death | At discharge | Serum bilirubin levels were associated with initial stroke severity closely but not short-term clinical outcomes among AIS patients. |
Ademiluyi et al 56 | Neurological impairment | NIHSS score | 1 | Severe stroke | NIHSS score >14 | 1 | AIS patients with higher physiological range of serum bilirubin had more severe stroke (higher NIHSS values). | |||
Sagheb Asl et al 59 | Death | Mortality | 14 | TBIL, DBIL and IBIL levels were significantly associated with mortality in AIS patients. | ||||||
Wang et al 55 | Neurological impairment | NIHSS score | 1, 7 and 14 | Disability | mRS | 30 | Poor functional outcome | mRS score >3 | 30 | Hyperbilirubinaemia might be a biomarker for a poor prognosis in the early identification of LAA strokes. |
AIS, acute ischaemic stroke; BI, Barthel Index; DBIL, direct bilirubin; IBIL, indirect bilirubin; LAA, large-artery atherosclerosis; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; TBIL, total serum bilirubin.